Andre Pereira Fraga Figueiredo
Direktor/Vorstandsmitglied bei GENETETHER THERAPEUTICS INC.
Vermögen: 64 077 $ am 31.05.2024
Profil
Mr. Andre Pereira Fraga Figueiredo is a General Manager at Aurea Holdings LLC and an Independent Director at GeneTether Therapeutics, Inc. He is on the Board of Directors at GeneTether Therapeutics, Inc. and GeneTether, Inc. He received his undergraduate degree from Portuguese Catholic University and an MBA from the Instituto de Empresa SL.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.03.2023 | 2 563 061 ( 6,63% ) | 64 077 $ | 31.05.2024 |
Aktive Positionen von Andre Pereira Fraga Figueiredo
| Unternehmen | Position | Beginn |
|---|---|---|
| GENETETHER THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 01.01.2021 |
GeneTether, Inc.
 GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Direktor/Vorstandsmitglied | - |
| Aurea Holdings LLC | Gründer | 01.01.2021 |
Ausbildung von Andre Pereira Fraga Figueiredo
| Instituto de Empresa SL | Masters Business Admin |
| Portuguese Catholic University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENETETHER THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Commercial Services |
| Aurea Holdings LLC |
